Wall Street’s Evan David Seigerman stirred the pot by slashing his price target on Eli Lilly stock—but not his enthusiasm.

Natixis has significantly reduced its investment in Bank of America, trimming its stake by nearly 23% in the fourth quarter.

Procter & Gamble saw a significant shakeup in shareholder activity, especially as Ossiam slashed its holdings by more than ...

Tower Research Capital gave Johnson & Johnson’s portfolio a serious vitamin boost, increasing its stake by 71.4% in Q4. The ...

First Trust Advisors LP beefed up its stake in Home Depot by snagging nearly 32,000 more shares, now owning 680,703 in total.

Berkshire Hathaway B is gaining investor attention, despite a recent dip in its stock performance. Over the past month, ...

Trajan Wealth LLC bulked up its Chevron stake by 7.6%, adding 2,372 shares and pushing its total to a 33,567-share pool worth ...

Representative Robert Bresnahan, Jr. of Pennsylvania recently ditched some Meta Platforms shares, selling between $1,001 and ...

AbbVie is set to report earnings on April 25, with revenue expected to top $13.17 billion and EPS hitting $2.44. Insiders at ...

Tesla teased investors with a promise of a new low-cost model by mid-2025, sparking initial excitement—until details emerged.

Sunpointe LLC added 142 more shares of Microsoft during Q4, bumping its stake to 15,170 shares worth around $6.4 million.

Merck is set to release its Q1 2025 earnings before markets open Thursday, with analysts eyeing $2.16 EPS on $15.59B revenue.